BIGBEAR
PHARMACEUTICALS
Capivasertib is the first approved highly selective ATP-competitive AKT kinase inhibitor, and is commonly used in combination with fulvestrant.
AuthenticGuaranteeFast DeliveryPrivacy Complete English TranslationCapivasertibCapivasertib is an oral targeted anti-cancer drug. It should be stored in a cool, dry place at a temperature b···【Read More】
Update: 16 Mar,2026Source: Haiou HealthViews: 71
Capivasertib is an oral small-molecule targeted drug whose primary mechanism of action involves inhibiting serine/threonine kinase. By blocking releva···【Read More】
Update: 16 Mar,2026Source: Haiou HealthViews: 71
Capivasertib is an oral small-molecule targeted drug whose primary mechanism of action involves inhibiting serine/threonine kinase. By blocking releva···【Read More】
Update: 16 Mar,2026Source: Haiou HealthViews: 69
Copyright2024@ BIGBEAR All right reserved BIGBEAR
